489 related articles for article (PubMed ID: 14597787)
21. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
Grünblatt E
Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
[TBL] [Abstract][Full Text] [Related]
22. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
[TBL] [Abstract][Full Text] [Related]
23. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
24. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
[TBL] [Abstract][Full Text] [Related]
25. More than the sum of its parts? Nutrition in Alzheimer's disease.
von Arnim CA; Gola U; Biesalski HK
Nutrition; 2010; 26(7-8):694-700. PubMed ID: 20381316
[TBL] [Abstract][Full Text] [Related]
26. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
Yeh HL; Tsai SJ
Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
28. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
29. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
Pham DQ; Plakogiannis R
Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
[TBL] [Abstract][Full Text] [Related]
30. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease.
Zhu BT
Int J Mol Med; 2004 Mar; 13(3):343-53. PubMed ID: 14767563
[TBL] [Abstract][Full Text] [Related]
31. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress.
Lau FC; Shukitt-Hale B; Joseph JA
Subcell Biochem; 2007; 42():299-318. PubMed ID: 17612057
[TBL] [Abstract][Full Text] [Related]
32. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL
Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448
[TBL] [Abstract][Full Text] [Related]
33. Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review.
Watt F
Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):17-26. PubMed ID: 8833663
[TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease and brain levels of organochlorine pesticides.
Fleming L; Mann JB; Bean J; Briggle T; Sanchez-Ramos JR
Ann Neurol; 1994 Jul; 36(1):100-3. PubMed ID: 7517654
[TBL] [Abstract][Full Text] [Related]
35. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
37. Vitamin E and neurodegenerative diseases.
Ricciarelli R; Argellati F; Pronzato MA; Domenicotti C
Mol Aspects Med; 2007; 28(5-6):591-606. PubMed ID: 17306357
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant approaches for the treatment of Alzheimer's disease.
Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G
Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
Mariani E; Polidori MC; Cherubini A; Mecocci P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
[TBL] [Abstract][Full Text] [Related]
40. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
